Dr. Bruyninckx Liesbet, huisarts
0542.920.084 · rovalta.com · 28/09/2026
Dr. Bruyninckx Liesbet, huisarts
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr. Bruyninckx Liesbet, huisarts is a Private limited company incorporated in 2013. Its main activity is: General medical practice activities. Its registered office is in Begijnendijk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0542.920.084
- Incorporation
- 12/12/2013
- Legal form
- Private limited company
- Registered office
- Prof.Scharpélaan 77
3130 Begijnendijk · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 153,9 k € | -1.0% | 155,4 k € | -1.9% | 158,4 k € | +13.2% | 139,9 k € | -2.4% | 143,4 k € |
| EBITDA | 151,9 k € | -1.0% | 153,5 k € | -1.9% | 156,4 k € | +13.2% | 138,2 k € | -2.4% | 141,6 k € |
| Operating result | 116,1 k € | -2.0% | 118,5 k € | +1.4% | 116,8 k € | +15.1% | 101,5 k € | -0.2% | 101,7 k € |
| Net result | 79,7 k € | -10.4% | 88,9 k € | +2.3% | 86,9 k € | +22.9% | 70,7 k € | -7.4% | 76,3 k € |
| Balance sheet | |||||||||
| Equity | 175,2 k € | -0.5% | 176,2 k € | 0.0% | 176,2 k € | -10.7% | 197,3 k € | +55.8% | 126,6 k € |
| Total assets | 545,1 k € | -10.2% | 607,1 k € | -8.8% | 665,3 k € | +3.4% | 643,8 k € | +13.5% | 567 k € |
| Cash | 110,3 k € | -3.5% | 114,4 k € | -21.2% | 145,2 k € | +22.6% | 118,4 k € | +31.3% | 90,2 k € |
| Debts | 369,9 k € | -14.2% | 430,9 k € | -11.9% | 489,1 k € | +9.6% | 446,5 k € | +1.4% | 440,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Liesbet Bruyninckx | Directorsince 11/12/2013Managerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/06/2026 | 24/03/2025 | 06/06/2024 | 04/04/2023 | 02/08/2022 | 16/08/2021 |
| General meeting | 12/06/2026 | 19/03/2025 | 04/06/2024 | 03/04/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 12/06/2026 | 15/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 19/03/2025 | 24/03/2025 | Dutch | |
| Micro model | 31/12/2023 | 04/06/2024 | 06/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 03/04/2023 | 04/04/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/06/2022 | 02/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/06/2021 | 16/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/05/2020 | 19/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 17/05/2019 | 23/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 18/05/2018 | 28/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 19/05/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/05/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 15/05/2015 | 28/08/2015 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Liesbet Bruyninckx | Directorsince 11/12/2013Managerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Prof.Scharpélaan 77, 3130 BegijnendijkCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00168581 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Bruyninckx Liesbet, huisartsCurrent | accounts 2014 → 2025 | Accounts 2025 · 2026-00168581 |
Events
- 2025Annual accounts 202579,7 k €↓
- 2024Annual accounts 202488,9 k €↑
- 2023Annual accounts 202386,9 k €↑
- 2022Annual accounts 202270,7 k €↓
- 2021Annual accounts 202176,3 k €↑
- 2020Annual accounts 20209,3 k €↑
- 2019Annual accounts 2019955,4 €↓
- 2018Annual accounts 201818,1 k €↑
- 2017Annual accounts 20178,2 k €↑
- 2016Annual accounts 201634,1 €↓
- 2015Annual accounts 2015762,6 €↓
- 2014Annual accounts 201413,8 k €
- 12/12/2013IncorporationPrivate limited company